Literature DB >> 16543063

Analysis of the effect of different NKT cell subpopulations on the activation of CD4 and CD8 T cells, NK cells, and B cells.

Henry Lin1, Mie Nieda, Vladislav Rozenkov, Andrew J Nicol.   

Abstract

OBJECTIVE: NKT cells have diverse immune regulatory functions including activation of cells involved in Th1- and Th2-type immune activities. Most previous studies have investigated the functions of NKT cells as a single family but more recent evidence indicates the distinct functional properties of NKT cell subpopulation. This study aims to determine whether NKT cell subpopulations have different stimulatory activities on other immune cells that may affect the outcome of NKT cell-based immunotherapy.
METHODS: NKT cells and NKT cell subpopulations (CD4(+)CD8(-), CD4(-)CD8(+), CD4(-)CD8(-)) were cocultured with PBMC and their activities on immune cells including CD4(+) and CD8(+) T cells, NK cells, and B cells were assessed by flow cytometry. The production of cytokines in culture was measured by enzyme-linked immunsorbent assay.
RESULTS: The CD4(+)CD8(-) NKT cells demonstrated substantially greater stimulatory activities on CD4(+) T cells, NK cells, and B cells than other NKT cell subsets. The CD4(-)CD8(+) NKT cells showed the greatest activity on CD8(+) T cells, and were the only NKT cell subset that activated these immune cells. The CD4(-)CD8(-) NKT cells showed moderate stimulatory activity on CD4(+) T cells and the least activity on other immune cells.
CONCLUSION: The results here suggest that NKT cell subpopulations differ in their abilities to stimulate other immune cells. This highlights the potential importance of manipulating specific NKT cell subpopulations for particular therapeutic situations and of evaluating subpopulations, rather than NKT cells as a group, during investigation of a possible role of NKT cells in various disease settings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16543063     DOI: 10.1016/j.exphem.2005.12.008

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  16 in total

1.  Ex-vivo analysis of human natural killer T cells demonstrates heterogeneity between tissues and within established CD4(+) and CD4(-) subsets.

Authors:  A C Chan; E Leeansyah; A Cochrane; Y d'Udekem d'Acoz; D Mittag; L C Harrison; D I Godfrey; S P Berzins
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

2.  Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro.

Authors:  Shijuan Grace Zeng; Yasmeen G Ghnewa; Vincent P O'Reilly; Victoria G Lyons; Ann Atzberger; Andrew E Hogan; Mark A Exley; Derek G Doherty
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

3.  Transcriptional control of invariant NKT cell development.

Authors:  Rupali Das; Derek B Sant'Angelo; Kim E Nichols
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

4.  Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis.

Authors:  Frederico J S Correa; Marina Paula Andres; Tainá Pezzin Rocha; Ana Eduarda Z Carvalho; Thiago P A Aloia; Marcus V N Corpa; Esper G Kallas; Cristóvão L P Mangueira; Edmund C Baracat; Karina I Carvalho; Mauricio S Abrão
Journal:  Clinics (Sao Paulo)       Date:  2022-05-13       Impact factor: 2.898

5.  The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells.

Authors:  Rivka Melamed; Ella Rosenne; Marganit Benish; Yael Goldfarb; Ben Levi; Shamgar Ben-Eliyahu
Journal:  J Immunother       Date:  2010-01       Impact factor: 4.456

Review 6.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

7.  Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11.

Authors:  Carlos J Montoya; David Pollard; Jeffrey Martinson; Kumud Kumari; Clive Wasserfall; Candice B Mulder; Maria T Rugeles; Mark A Atkinson; Alan L Landay; S Brian Wilson
Journal:  Immunology       Date:  2007-07-28       Impact factor: 7.397

8.  Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cells.

Authors:  Vincent O'Reilly; Shijuan G Zeng; Gabriel Bricard; Ann Atzberger; Andrew E Hogan; John Jackson; Conleth Feighery; Steven A Porcelli; Derek G Doherty
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

9.  The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation.

Authors:  Elisabeth Schrumpf; Xiaojun Jiang; Sebastian Zeissig; Marion J Pollheimer; Jarl Andreas Anmarkrud; Corey Tan; Mark A Exley; Tom H Karlsen; Richard S Blumberg; Espen Melum
Journal:  Physiol Rep       Date:  2017-02

10.  Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells.

Authors:  Naoko Mise; Mariko Takami; Akane Suzuki; Toshiko Kamata; Kazuaki Harada; Tomoro Hishiki; Takeshi Saito; Keita Terui; Tetsuya Mitsunaga; Mitsuyuki Nakata; Takayuki Ikeuchi; Toshinori Nakayama; Hideo Yoshida; Shinichiro Motohashi
Journal:  Cancer Sci       Date:  2016-02-09       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.